In Vivo Drug Interaction Study

Sponsor: CONRAD(Contraceptive Research and Dev)

Location(s): United States


This Phase I, randomized multi-site study aimed to determine if concomitant administration of Tenofovir (TFV) 1% vaginal microbicide gel and a non-microbicide vaginal product (antifungal cream, antimicrobial gel, or the combination contraceptive intravaginal ring [IVR]) changes local and/or systemic exposure compared to TFV alone or vaginal product alone.